Your session is about to expire
← Back to Search
Procedure
Focused Ultrasound for Obsessive-Compulsive Disorder
N/A
Waitlist Available
Led By Nir Lipsman, MD, PhD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new treatment using focused ultrasound waves guided by MRI for patients with OCD who haven't responded to other treatments. The treatment works by heating and destroying a small part of the brain to change its activity.
Eligible Conditions
- Obsessive-Compulsive Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of Treatment-Emergent Adverse Events [Safety]
Secondary study objectives
Clinically meaningful reduction in symptoms [Efficacy]
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Focused UltrasoundExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Focused Ultrasound
2012
Completed Phase 2
~50
Find a Location
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
674 Previous Clinical Trials
1,565,843 Total Patients Enrolled
9 Trials studying Obsessive-Compulsive Disorder
798 Patients Enrolled for Obsessive-Compulsive Disorder
Hotchkiss Brain Institute, University of CalgaryOTHER
11 Previous Clinical Trials
2,420 Total Patients Enrolled
1 Trials studying Obsessive-Compulsive Disorder
120 Patients Enrolled for Obsessive-Compulsive Disorder
Nir Lipsman, MD, PhDPrincipal InvestigatorSunnybrook Health Sciences Centre, Sunnybrook Research Institute
3 Previous Clinical Trials
22 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger